A 50-year-old Black woman with alopecia areata and traction alopecia is seeking a science-based hairloss routine. Current treatments include spearmint tea for DHT levels and considering PRP.
A new study that found a single chemical could potentially be responsible for hairloss, and the potential to use this discovery to stimulate hair growth. The conversation also includes various treatments such as Minoxidil, Finasteride, RU58841, microneedling, DUT, and Botox for hairloss.
Clinical studies by Dr. Barghouthi and Dr. Bloxham indicate that Verteporfin, when used with FUE and FUT hair transplantation methods, shows promise in hair follicle regeneration and minimal scarring due to its ability to inhibit Yes-associated protein (YAP). Microneedling at depths of 3-3.5mm, combined with Verteporfin, could potentially reactivate dormant follicles, although the optimal dosage and application method are still under investigation. Concerns remain about the DHT sensitivity of regenerated follicles, highlighting the need for further research to optimize trauma levels and Verteporfin concentrations to achieve effective and scar-free hair regeneration.
The conversation discusses whether finasteride would still be necessary if Verteporfin becomes a successful hairloss treatment. It also explores the sensitivity of transplanted hair to DHT and the potential for off-label use of Verteporfin post hair transplant.
Rob English's scalp massages are discussed as a method to reduce DHT and stop hairloss, but many users criticize it as ineffective compared to treatments like finasteride, dutasteride, and minoxidil. Some users argue that alternative treatments like scalp massages and microneedling can work for some, but the community largely favors the "big three" medications.
A user shared 14-month progress pictures using topical finasteride and minoxidil for hairloss. Others commented on the impressive results and asked about age, improvement timeline, and how to obtain finasteride.
The conversation discusses the use of a derma roller versus a derma stamp for microneedling to prevent hairloss. The user has been using topical minoxidil for 2 months without results and seeks advice on needle length.
A user in France is frustrated because three dermatologists refused to prescribe finasteride for their hairloss, suggesting it's not androgenetic alopecia (AGA) and offering expensive vitamin treatments instead. Other users suggest buying hairloss treatments like minoxidil and finasteride from various online pharmacies and considering a gender-affirming care physician for more understanding treatment options.
The conversation discusses Dr. Blake Bloxham's experiment with Verteporfin for hairloss, with one person suggesting more doctors should try it as it seems beneficial. Another comment notes that results at 4-5 months were not very impressive.
A 29-year-old woman is experiencing gradual hair thinning since age 15, suspects Androgenic Alopecia, and has tried 5% minoxidil with little success. She has purchased various hairloss treatments including minoxidil, dutasteride, finasteride, and spironolactone, but is cautious about starting them due to potential interactions with her ADHD medication.
A man who claimed to have regrown his hair using stem cell treatment, sparking a debate about its effectiveness and cost. Some users suggested he might be using other treatments or substances, while others shared their own experiences with stem cell therapy for hairloss.
The post and conversation are about a user's progress with microneedling and minoxidil for hairloss. The user is happy with the progress and plans to continue with the treatment, without using finasteride.
The efficacy of microneedling for hair regrowth as either a stand-alone therapy or adjunct to Minoxidil, and whether Tretinoin is a safer and more effective option. Replies include personal accounts from users who have had success with microneedling in combination with minoxidil and peptide serums, as well as considerations of technique, depth, and potential scarring.
A 25-year old user's progress with only finasteride in treating their hairloss, and other users suggesting minoxidil and dermarolling as additional treatments.
The conversation is about creating a higher concentration of the newly FDA-approved hairloss treatment, Clascoterone (Winlevi), through compounding pharmacies and possibly organizing group purchases. Some users are unfamiliar with Winlevi and are asking for an explanation of the drug.
Young men are advised to delay hair transplants until after age 25, using finasteride, minoxidil, and dermarolling to manage hairloss. Concerns about unethical doctors highlight the need for careful planning.
A user shared their positive experience with a 3500 graft FUT hair transplant by Dr. Scott Alexander in Phoenix, AZ, costing $14,000. They are using a daily Hims finasteride and minoxidil tablet and are pleased with the results, despite some initial concerns about scarring.
A 22-year-old male has been using finasteride, topical minoxidil, and oral minoxidil for hairloss but sees minimal improvement and is considering adding dutasteride. Users suggest additional treatments like dermarolling, PRP, and consulting a dermatologist, or considering a hair transplant.
The conversation discusses how many male models and celebrities likely use finasteride to prevent hairloss, with some expressing surprise that it's not just good genetics keeping their hair intact. Specific treatments mentioned include finasteride and, in one query, minoxidil.
A young man in his mid-20s started using finasteride and biotin for hair thinning and has seen less hairloss after three months. Others shared their positive experiences with minoxidil and finasteride, discussed potential side effects, and encouraged early treatment for hairloss.
DUPA is considered more treatable than FAPD, as FAPD involves scarring that prevents hair regrowth. The user has started treatment with oral dutasteride and minoxidil, hoping for better results than previous treatments.
Adding RU58841 to a regimen of 2.5 mg dutasteride and 5 mg oral minoxidil for potential hair regrowth. Some users suggest a biopsy to determine the cause of hairloss, while others discuss the effectiveness and side effects of various treatments.
Pelage is moving to Phase III clinical trials for PP405, a hairloss treatment, with results to be presented at a medical meeting. Users express skepticism and hope, comparing it to existing treatments like Minoxidil and finasteride, while discussing the potential for new hair growth in previously bald areas.
The user has been using oral finasteride and minoxidil, along with biotin, vitamin D3, collagen, and micro-needling, to address hairloss over six months. They experienced some shedding initially but have seen progress, with improved hair quality and reduced bald spots.
A 32-year-old male is considering options to soften a dense transplanted hairline after experiencing accelerated hairloss and intolerance to finasteride and dutasteride, while using minoxidil. He is exploring partial electrolysis or laser treatments to achieve a natural look with a short buzz cut, avoiding a second transplant or scalp micropigmentation.
A user is considering using verteporfin with microneedling, oral/topical minoxidil, and RU58841 to treat hairloss. They seek advice on dosage and application methods.
The user had a detailed 3.5-hour consultation with Dr. Zarev for hairloss treatment, praising his meticulous approach and innovative techniques, and was prescribed topical finasteride and minoxidil. Other users agreed on Zarev's expertise, noting his long waiting list and the high quality of his work, with one surgery per week and a focus on individual patient care.
The user does not respond well to minoxidil and is seeking an alternative to Tretinoin to upregulate sulfurtransferase activity for hairloss treatment. No specific alternative treatments were mentioned.